Company intelligence / Profile preview

LIFETEST Imaging

Tel Aviv, Israel

Ownership: Private
Employees: ~25
Development stage: Other

Overview

LifeTest is a medical technology company focused on the early detection of cancer through advanced diagnostic solutions. The company utilizes a proprietary liquid biopsy platform that combines high-sensitivity molecular assays with artificial intelligence to identify cancer biomarkers in the blood at their earliest stages. By integrating imaging data with molecular results, LifeTest aims to provide a more comprehensive and accurate screening process for various types of cancer. Their services are designed to improve patient outcomes by enabling earlier intervention and personalized treatment planning.

Therapeutic areas: Oncology
Modalities: Liquid biopsyDiagnostic testArtificial Intelligence
Industry: Molecular Diagnostics

Partnerships

Various clinical research organizationsOncology centers

Beyond the preview

Go deeper on LIFETEST Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LIFETEST Imaging.

Explore the full profile